Skip to content

injection of same persons blood blood in the Temperomandibular joint in the treatment of repeated Temporo mandibular joint Displacement.

COMPARISION OF AUTOLOGUS BLOOD INJECTION WITH DEXTROSE PROLOTHERAPY IN THE TREATMENT OF RECURRENT TMJ DISLOCATION -A PROSPECTIVE, RANDOMISED CLINICAL TRIAL.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028382
Enrollment
36
Registered
2020-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M258- Other specified joint disorders

Interventions

Intervention1: Autologous Blood Injection: 3ml of Autologous blood would be withdrawn from patients anticubital fossa in a 5ml syringe 2ml will be injected into the upper joint space and 1 ml will be

Sponsors

Government dental college and hospital mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pt.â??s showing episodes of TMJ 2.dislocation (unilateral/bilateral) twice or thrice in 6 months to 1 year. 3.Maximal mouth opening more than (35-42) mm 4.Clinical examination of TMJ. ï?? Crepitus or clicking sounds in TMJ. ï?? Radiographic evidence of TMJ dislocation. ï?? Patients giving consent for the study.

Exclusion criteria

Exclusion criteria: ï?? Psychiatric conditions ï?? Connective tissue syndromes. ï?? Short lower facial thirds (leads to joint instability) ï?? Mentally retarded patients ï?? Patients with bleeding disorders ï?? Pregnant patients ï?? Patient allergic to local or topical anaesthetic ï?? Patients not giving consent.

Design outcomes

Primary

MeasureTime frame
1) TMJ Pain (0-10 Visual Analogue Scale) 2) episodes of dislocations per week in past Timepoint: 1) 3RD DAY & 7th and 15th day on follow up 2) 6 months,follow up 6th months and 1 year

Secondary

MeasureTime frame
1) Maximal mouth opening in mm 2) Joint sounds in TMJ (absent/present) Timepoint: 1)15 day,follow up 3rd,6th month and 1 year. 2)15 day,foolow up 3rd ,6th month and 1 year

Countries

India

Contacts

Public ContactAshwini Pradeep Chhapane

GDC mumbai

dr.kavitawadde@gmail.com9004799405

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026